Crisis Mode R&D: A Conversation with GSK, MSD and Sanofi
28 May 2020 – As the number of COVID-19 cases hits 5.4 million globally, the race is on to find treatments and a vaccine. At the joint MBC-USABC event “Crisis Mode R&D”, the Philippine heads of three global pharmaceutical companies — Beaver Tamesis of MSD; Jean-Antoine Zinsou from Sanofi Pasteur; and Zainab Sadat of GSK — shed light on the challenges of vaccine research and development in crisis-mode.